Paul-Gydéon Ritvo

Title: Paul-Gydéon Ritvo: Innovator in Immunotherapy

Introduction

Paul-Gydéon Ritvo is a notable inventor based in Paris, France. He has made significant contributions to the field of immunotherapy, particularly in the treatment of autoimmune and inflammatory disorders. His innovative approach combines interleukin-2 with an interleukin-1 inhibitor, showcasing his expertise in therapeutic applications.

Latest Patents

Ritvo holds a patent for the invention titled "Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof." This patent relates to a combination of interleukin-2 (IL-2) and an interleukin-1 (IL-1) inhibitor, aimed at treating autoimmune and inflammatory disorders in subjects. The invention also includes a pharmaceutical composition comprising IL-2 and an IL-1 inhibitor, as well as a conjugate that features IL-2 conjugated to an IL-1 inhibitor. He has 1 patent to his name.

Career Highlights

Throughout his career, Ritvo has worked with prominent organizations, including Iltoo Pharma and Sorbonne Université. His work in these institutions has allowed him to advance his research and contribute to the development of innovative therapies.

Collaborations

Ritvo has collaborated with esteemed colleagues such as David Klatzmann and Jérémie Mariau. These partnerships have enriched his research and expanded the impact of his inventions in the field of immunotherapy.

Conclusion

Paul-Gydéon Ritvo is a distinguished inventor whose work in immunotherapy has the potential to transform treatment options for autoimmune and inflammatory disorders. His innovative patent and collaborations highlight his commitment to advancing medical science.